Page 76 - MI-2-3

Microbes & Immunity Natural phage patentability in the U.S.

relationships that could be construed as a potential conflict us/566/66 [Last accessed on 2024 Oct 18].
of interest. 4. Justia US Supreme Court Center. Association for Molecular
Pathology v. Myriad Genetics, Inc., 569 U.S. 576; 2013.
Author contributions Available from: https://supreme.justia.com/cases/federal/
Conceptualization: Nannan Wu, Tongyu Zhu, Qimao Yang us/569/576 [Last accessed on 2024 Oct 18].
Writing – original draft: Qimao Yang, Shiyi Zeng 5. Justia US Supreme Court Center. Alice Corp. v. CLS Bank
Writing – review & editing: Nannan Wu, Tongyu Zhu, Biao Int’l, 573 U.S. 208; 2014. Available from: https://supreme.
Zhu justia.com/cases/federal/us/573/208 [Last accessed on
2024 Oct 18].
Ethics approval and consent to participate 6. European Patent Office. Biotechnological Inventions; Ch. 5.
Not applicable. Available from: https://www.epo.org/en/legal/epc/2020/
rcii_v.html [Last accessed on 2024 Oct 18].
Consent for publication 7. European Patent Office. Patentability. Ch. 1. Available from:
Not applicable. https://www.epo.org/en/legal/epc/2020/acii_i.html [Last
accessed on 2024 Oct 18].
Availability of data 8. IP Australia. What Biological Inventions can be Patented.

Not applicable. Available from: https://www.ipaustralia.gov.au/patents/
what-are-patents/what-biological-inventions-can-be-
References patented [Last accessed on 2024 Oct 18].

1. Sacher J. Breaking down Phage Patentability. Capsid and 9. FitzGerald MJ, Spek EJ. Microbiome therapeutics and patent
Tail. Vol. 13; 2019. Available from: https://phage.directory/ protection. Nat Biotechnol. 2020;38(7):806-810.
capsid/phage-patentability [Last accessed on 2024 Oct 18]. doi: 10.1038/s41587-020-0579-z
2. Todd K. The promising viral threat to bacterial resistance: 10. Grabowski H. Patents, innovation and access to new
The uncertain patentability of phage therapeutics and the pharmaceuticals. J Int Econ Law. 2002;5(4):849-860.
necessity of alternative incentives. Duke Law J. 2019;68:
767-805. doi: 10.1093/jiel/5.4.849
11. Yang Q, Le S, Zhu T, Wu N. Regulations of phage therapy
3. Justia US Supreme Court Center. Mayo Collaborative
Services v. Prometheus Laboratories, Inc., 566 U.S. 66; 2012. across the world. Front Microbiol. 2023;14:1250848.
Available from: https://supreme.justia.com/cases/federal/ doi: 10.3389/fmicb.2023.1250848

Volume 2 Issue 3 (2025) 68 doi: 10.36922/mi.4758